PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 186 filers reported holding PDL BIOPHARMA INC in Q3 2017. The put-call ratio across all filers is 1.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $596,000 | -84.6% | 189,866 | -81.7% | 0.00% | -82.4% |
| Q1 2019 | $3,861,000 | -41.7% | 1,037,846 | -54.5% | 0.02% | -48.5% |
| Q4 2018 | $6,621,000 | -10.0% | 2,282,719 | -18.4% | 0.03% | +10.0% |
| Q3 2018 | $7,356,000 | -21.4% | 2,797,204 | -30.1% | 0.03% | -25.0% |
| Q2 2018 | $9,359,000 | -33.0% | 3,999,658 | -15.8% | 0.04% | -33.3% |
| Q1 2018 | $13,964,000 | -3.5% | 4,749,459 | -10.1% | 0.06% | -4.8% |
| Q4 2017 | $14,471,000 | -19.2% | 5,281,288 | 0.0% | 0.06% | -20.3% |
| Q3 2017 | $17,904,000 | +50.3% | 5,281,288 | +9.5% | 0.08% | +46.3% |
| Q2 2017 | $11,913,000 | +8.8% | 4,822,932 | -0.1% | 0.05% | +8.0% |
| Q1 2017 | $10,951,000 | -6.1% | 4,825,688 | -12.3% | 0.05% | -12.3% |
| Q4 2016 | $11,665,000 | -42.9% | 5,503,285 | -9.7% | 0.06% | -43.6% |
| Q3 2016 | $20,420,000 | +4.3% | 6,095,925 | -2.2% | 0.10% | +1.0% |
| Q2 2016 | $19,578,000 | -3.3% | 6,235,824 | +2.6% | 0.10% | -2.0% |
| Q1 2016 | $20,243,000 | -7.1% | 6,079,290 | -1.2% | 0.10% | -10.5% |
| Q4 2015 | $21,791,000 | +21.8% | 6,155,450 | +73.0% | 0.11% | +16.3% |
| Q3 2015 | $17,897,000 | -40.6% | 3,558,025 | -24.1% | 0.10% | -32.9% |
| Q2 2015 | $30,144,000 | -33.6% | 4,687,973 | -27.4% | 0.15% | -30.5% |
| Q1 2015 | $45,416,000 | -1.4% | 6,455,584 | +8.1% | 0.21% | +2.4% |
| Q4 2014 | $46,042,000 | -6.5% | 5,971,673 | -9.4% | 0.20% | -13.9% |
| Q3 2014 | $49,250,000 | -21.6% | 6,593,444 | +1.6% | 0.24% | -22.0% |
| Q2 2014 | $62,795,000 | +34.9% | 6,487,012 | +15.8% | 0.30% | +25.0% |
| Q1 2014 | $46,548,000 | -3.5% | 5,601,512 | -2.0% | 0.24% | -9.3% |
| Q4 2013 | $48,239,000 | +7.6% | 5,715,572 | +1.6% | 0.27% | -7.6% |
| Q3 2013 | $44,828,000 | – | 5,624,377 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Chapters Capital Management LLC | 119,700 | $254,000 | 0.43% |
| GSA CAPITAL PARTNERS LLP | 1,587,756 | $3,366,000 | 0.20% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 60,901 | $129,110,000 | 0.14% |
| Acrospire Investment Management LLC | 129,480 | $274,000 | 0.11% |
| SECOR Capital Advisors, LP | 410,323 | $870,000 | 0.11% |
| RBF Capital, LLC | 251,421 | $540,000 | 0.08% |
| Park West Asset Management LLC | 400,000 | $848,000 | 0.07% |
| MACKENZIE FINANCIAL CORP | 4,687,825 | $9,938,000 | 0.06% |
| CIGNA INVESTMENTS INC /NEW | 261,533 | $554,000,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 5,503,285 | $11,665,000 | 0.06% |